Reuters logo
BRIEF-Arcus Biosciences announces $107 mln series C financing
November 13, 2017 / 12:39 PM / 9 days ago

BRIEF-Arcus Biosciences announces $107 mln series C financing

Nov 13 (Reuters) -

* Arcus Biosciences announces $107 million series c financing led by gv and initiation of two clinical trials

* Arcus Biosciences​ says ‍proceeds from financing to be used for advancement of co’s clinical programs for ab928 and ab122, a pd-1 antibody Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below